What is the focus of our program—What questions are
The Metabolic Disease program at Sanford/Burnham is focused on metabolic diseases that primarily affect the metabolic syndrome, which refers to metabolic complications that influence development of cardiovascular disease, obesity and type II diabetes. Metabolic Syndrome develops when the body’s normal process of sensing dietary nutrients for utilization of energy and storage are fundamentally perturbed through genetic, epigenetic or environmental mechanisms.
How will our research help patients?
Research in the Metabolic Disease program will help decipher the fundamental cellular defects associated with metabolic diseases and how individual molecular defects combine to influence outward disease phenotypes. Through robust collaborations with our clinical partners at the TRI-MD at Florida Hospital and others, these discoveries will leading to development of both diagnostic tools and therapeutic strategies to help further prevent the development and manifestation of metabolic disease symptoms in patients.